Moleculin Biotech Inc. (MBRX) |
|
0.9335 -0.026 (-2.7%)
|
01-21 16:00 |
|
Open: |
0.925 |
Pre. Close: |
0.9594 |
|
High:
|
0.94 |
Low:
|
0.9002 |
|
Volume:
|
358,866 |
Market Cap:
|
43M |
|
|
|
|
Moleculin Biotech Inc is a preclinical stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.942 - 0.947 |
0.947 - 0.951 |
|
Low:
|
0.887 - 0.894 |
0.894 - 0.899 |
|
Close:
|
0.921 - 0.931 |
0.931 - 0.938 |
|
Technical analysis |
as of: 2020-01-21 4:28:02 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.12 One year: 1.20 |
| Support: |
Support1: 0.85 Support2: 0.71 |
| Resistance: |
Resistance1: 0.96 Resistance2: 1.03 |
| Pivot: |
0.94 |
| Moving Average: |
MA(5): 0.95 MA(20): 0.95
MA(100): 1.05 MA(250): 1.16 |
| MACD: |
MACD(12,26): -0.02  Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 59.71 %D(3): 59.19 |
| RSI: |
RSI(14): 42.30 |
| 52-week: |
High: 3.15 Low: 0.78 Change(%): -29.8 |
| Average Vol(K): |
3-Month: 23821 10-Days: 19282 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.MBRX has closed above bottom band by 46.3%. Bollinger Bands are 42.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MBRX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-12-19
Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
HOUSTON, Dec. 19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced the presentation of a poster entitled,…
2019-12-04
Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug…
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
